India Diabetes Market: Trend, Size and Demand Forecast (2025-2034)

India has one of the highest incidences of diabetes globally, which has led to a rapid increase in the demand for diabetes-related healthcare products and services. The diabetes market in India was valued at INR 316.00 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 16.00% from 2025 to 2034. This growth will push the market size to INR 1394.01 billion by 2034. The rise in diabetes prevalence, changing lifestyle factors, and increased healthcare awareness are the primary factors fueling this market's growth.

Get a free sample report in India Diabetes Market: https://shorturl.at/e1chj

India Diabetes Market Overview

The India diabetes market in India plays a crucial role in addressing the health challenges posed by the increasing burden of diabetes in the region. With more than 70 million people currently living with diabetes, the market has expanded in both pharmaceutical and medical device segments. The widespread adoption of diabetes medications, such as insulin-based and non-insulin-based treatments, is driving this market. Additionally, India's growing middle class and improved access to healthcare services have increased the demand for diabetes management solutions. The availability of innovative treatments, diagnostic tools, and technologies are also shaping the market landscape.

Market Size and Share

As of 2024, the Indian diabetes market is valued at INR 316.00 billion, and the market is expected to grow at a CAGR of 16.00% from 2025 to 2034. This growth is driven by the increasing number of diabetes cases, which are expected to continue rising due to lifestyle changes, urbanization, and genetic factors. By 2034, the diabetes market in India is projected to reach INR 1394.01 billion. The market is driven by the high adoption of insulin and non-insulin treatments, and a significant portion of the growth will come from pharmaceutical and therapeutic segments, which are becoming increasingly innovative in managing diabetes.

Read full report with table of content in India Diabetes Market: https://shorturl.at/EGOOr

Market Trends

Increasing Prevalence of Type 2 Diabetes

Type 2 diabetes accounts for the majority of diabetes cases in India. The rising adoption of sedentary lifestyles, unhealthy diets, and high levels of stress are contributing to an increase in Type 2 diabetes. The growing number of elderly individuals in the population, combined with the rising incidence of obesity, is also driving the prevalence of Type 2 diabetes in India. This trend is creating a higher demand for lifestyle management and medication tailored to Type 2 diabetes patients.

Innovative Diabetes Treatments and Technologies

The diabetes market in India is witnessing the introduction of innovative treatments and technologies. New insulin analogs, oral hypoglycemics, and non-insulin biologics are being introduced by pharmaceutical companies. Furthermore, advancements in diabetes management devices, such as continuous glucose monitors (CGMs) and insulin pumps, are enabling better glucose control and improving patient outcomes. These innovations are helping patients manage diabetes more effectively and reducing long-term complications associated with the disease.

Shift Towards Non-Insulin-Based Treatments

While insulin remains the primary treatment for Type 1 and Type 2 diabetes, there is a notable shift towards non-insulin-based treatments. Oral medications such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists are gaining popularity, especially for Type 2 diabetes patients. These treatments provide an alternative to insulin therapy and have fewer side effects, making them an attractive option for patients and healthcare providers alike. This shift is expected to significantly contribute to the market's growth in the coming years.

Increasing Focus on Preventive Healthcare

With the rise in diabetes cases, the focus on preventive healthcare is increasing in India. More individuals are being encouraged to undergo routine screenings, especially in high-risk populations such as those with a family history of diabetes, the elderly, and overweight individuals. Governments and healthcare organizations are also launching awareness programs to educate people about the risks of diabetes and the importance of early diagnosis and management. This trend is expected to contribute to the growth of the diabetes market by promoting early intervention and timely treatment.

Market Analysis

Type-Based Segmentation

The diabetes market in India is divided primarily into Type 1 and Type 2 diabetes segments. Type 1 diabetes, which is primarily diagnosed in children and young adults, requires lifelong insulin therapy. However, the larger share of the market is taken by Type 2 diabetes, which is most commonly associated with adult onset and lifestyle factors. The increase in the number of Type 2 diabetes cases is driving demand for both pharmaceutical treatments and lifestyle management services.

Treatment Type Segmentation

The treatment options for diabetes are divided into insulin-based and non-insulin-based treatments, as well as others. Insulin-based treatments are crucial for managing both Type 1 and severe Type 2 diabetes. However, non-insulin-based treatments are becoming more prevalent in Type 2 diabetes management. These include oral medications such as metformin, DPP-4 inhibitors, and SGLT2 inhibitors, which are less invasive and preferred by many patients, especially in the early stages of Type 2 diabetes.

Route of Administration Segmentation

The route of administration for diabetes treatments includes oral, parenteral (injections), and other forms such as creams and gels. Oral medication is the most common form of administration, particularly for non-insulin-based treatments. Parenteral administration, which includes insulin injections, remains essential for managing Type 1 diabetes and advanced Type 2 diabetes. Additionally, the emergence of insulin pens and pumps is making insulin delivery more convenient and precise for patients.

End-User Segmentation

The primary end-users of diabetes treatments include hospitals, specialty clinics, homecare settings, and others. Hospitals and specialty clinics are the primary settings for the treatment of diabetes, especially for those with complications or requiring specialized care. Homecare settings are gaining popularity, as many patients prefer managing their diabetes at home with the help of remote monitoring devices and telemedicine services. The growing demand for homecare settings is contributing to the expansion of the market.

Scope of the Report

This report provides a detailed analysis of the India diabetes market, including historical trends, current market conditions, and future projections. The report covers various segments such as diabetes type, treatment type, doses form, route of administration, end-user, and distribution channels. It also includes insights into regional dynamics and identifies key market drivers, restraints, and opportunities. The report aims to offer stakeholders a comprehensive understanding of the market landscape and help guide strategic decision-making.

Regional Insights

Asia Pacific

India, being one of the most populous countries in Asia, plays a pivotal role in the diabetes market within the Asia Pacific region. The increasing burden of diabetes, combined with the rise in urbanization and lifestyle changes, is propelling the growth of the market in India. The availability of advanced diabetes care, coupled with a large population base, makes India one of the largest markets for diabetes treatments in the Asia Pacific region.

Global Trends Impacting India

The global diabetes market is witnessing several trends, such as advancements in biologics, the growing popularity of oral medications, and improved diabetes devices. India is benefiting from these trends, with global companies introducing innovative treatments and technologies in the Indian market. Additionally, regulatory frameworks and healthcare policies aimed at reducing diabetes prevalence are likely to help drive the market forward in the coming years.

Market Growth

The India diabetes market is poised for significant growth due to several factors. The rising prevalence of diabetes, particularly Type 2 diabetes, driven by sedentary lifestyles, obesity, and aging populations, is a key factor contributing to this growth. Furthermore, advancements in diabetes treatments, including insulin therapy and non-insulin-based medications, will continue to drive market expansion. The increasing adoption of preventive care practices, government initiatives to improve healthcare infrastructure, and a growing focus on diabetes education are also expected to create substantial opportunities for market growth.

Recent Developments & Challenges in India Diabetes Market

Emerging Insulin Therapies

Recent advancements in insulin therapies, such as the development of biosimilar insulin and long-acting insulin, are enhancing the treatment options available for diabetes patients. These innovations provide more effective and affordable options for insulin-dependent diabetes management, thereby improving patient outcomes.

Government Initiatives

The Indian government has been actively promoting diabetes awareness and prevention through various health campaigns. Programs aimed at increasing screenings, promoting healthy lifestyles, and providing affordable access to diabetes treatment have helped curb the rising number of diabetes cases. These initiatives are expected to support the growth of the diabetes market.

Challenges in Rural Areas

While the diabetes market in urban areas continues to expand, rural regions face challenges in terms of access to quality healthcare. The lack of healthcare facilities and trained professionals in rural areas is hindering effective diabetes management. Addressing these disparities is crucial for ensuring equitable access to diabetes care across India.

Rising Cost of Diabetes Care

The increasing cost of diabetes medications and treatments poses a challenge, particularly for low-income and middle-class families. While insurance coverage is improving, many people still struggle with the high cost of treatments. Innovative cost-effective solutions and government subsidies will play a vital role in addressing this challenge.

Key Players

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceuticals is a leading player in the Indian diabetes market, offering a wide range of diabetes management solutions. The company focuses on both insulin and non-insulin therapies, with several products aimed at improving patient outcomes. Sun Pharma has a strong presence in both domestic and international markets, contributing to the expansion of the diabetes market in India.

Biocon Limited

Biocon is a prominent biotechnology company in India that has made significant advancements in the field of diabetes treatment. With its portfolio of insulin products and biosimilars, Biocon is addressing the growing demand for affordable diabetes therapies. The company's focus on innovative biologic treatments has positioned it as a key player in the market.

Novo Nordisk India Pvt. Ltd.

Novo Nordisk is a global leader in diabetes care and has a strong presence in India. The company offers a comprehensive range of insulin products, as well as non-insulin-based treatments for Type 2 diabetes. Novo Nordisk's innovative approach to diabetes management, coupled with its strong distribution network, makes it a major player in the Indian market.

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is a leading pharmaceutical company in India, offering a wide range of generic and branded diabetes medications. The company is focused on providing cost-effective treatment options, including both oral medications and injectable therapies, to cater to the diverse needs of diabetic patients in India.

Other Companies

Sanofi India Limited, Eli Lilly and Company (India) Pvt. Ltd., Johnson & Johnson Private Limited, Abbott India Limited, Glenmark Pharmaceuticals Ltd., AstraZeneca Pharma India Limited, Lupin Limited, and Torrent Pharmaceuticals Ltd. are also key players in the India diabetes market, contributing to its growth and innovation.

FAQs

Q: What are the main drivers of the India diabetes market?
The key drivers include the rising prevalence of diabetes, increased healthcare awareness, innovations in diabetes treatments, and the adoption of preventive healthcare measures.

Q: How is the market for non-insulin-based treatments growing?
The market for non-insulin-based treatments is growing rapidly due to their fewer side effects, ease of administration, and effectiveness in managing Type 2 diabetes.

Q: What challenges does the diabetes market face in India?
Challenges include limited access to healthcare in rural areas, the high cost of diabetes medications, and the increasing burden of diabetes-related complications.

Q: What are the most commonly used forms of diabetes treatments in India?
Tablets, injections, and insulin-based therapies are the most commonly used forms of diabetes treatments in India, with oral medications being preferred for Type 2 diabetes management.

Read More Report:

Top 8 Viral Inactivation Firms: https://shorturl.at/Ge35c

Global Vessel Sealing Device Market: https://shorturl.at/xnZ22

Top 7 Pediatric Medical Device Companies & Manufacturers Worldwide: https://rb.gy/npfor4

Top 7 Spectrophotometer Companies in the Global Market: https://rb.gy/whkpif

India Healthcare Investment Surge: https://shorturl.at/8ClQT

Media Contact:

Company Name: Claight Corporation
Contact Person: Harry William, Corporate Sales Specialist - U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.